Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, with reference to the report of the Independent Cancer Taskforce, Achieving world-class cancer outcomes: A strategy for England 2015-2020, published in July 2015, what progress has been made on implementation of recommendation 47 on NHS England commissioning NICE to develop updated guidelines for adjuvant treatment for breast cancer.

The National Institute for Health and Care Excellence’s (NICE) guideline on early and locally advanced breast cancer: diagnosis and management (CG80) recommends the use of adjuvant bisphosphonates for the management of breast cancer treatment-induced bone loss in specified clinical circumstances. This guideline is currently being updated and the use of adjuvant bisphosphonates has been identified as one of the key areas that will be covered in this update. NICE expects to publish its updated guideline in July 2018.